Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

OKX United States
okx.com > en-us > price > eli-lilly-and-company-xlly

Eli Lilly and Company Price Today | xLLY Live Price, Chart & Market Cap

2+ day, 15+ hour ago   (74+ words) Earn more while paying less with flexible yield options and zero hidden fees. Buy, sell, and convert crypto with zero platform fees. Keep more of your profit in your pocket. Watch your rewards compound automatically when you stake 50+ assets with…...

The Globe and Mail
theglobeandmail.com > investing > markets > markets-news > motley > 4505610 > prediction-this-is-what-a-5-000-investment-in-eli-lilly-will-be-worth-in-2031

Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031

3+ day, 19+ hour ago   (165+ words) Eli Lilly has crushed broader equities in recent years. The company's leadership in the fast-growing GLP-1 market grants it attractive medium-term prospects. The stock can deliver competitive returns over the next five years. LLY Revenue (Annual) data by YCharts The…...

Google News
kalkinemedia.com > us > news > announcements > eli-lilly-executive-vice-president-eric-dozier-retains-14239-shares-following-gift-transaction

ELI LILLY Executive Vice President Eric Dozier Retains 14,239 Shares Following Gift Transaction

4+ day, 8+ hour ago   (130+ words) Why Did Newmont (NYSE:NEM) Slide Even As Gold Sits Near Record Highs? On September 2, 2026, ELI LILLY & Co executive Eric Dozier transferred 216 shares as a gift at $0 per share. Post-transaction, Dozier maintains ownership of 14,239 shares, reflecting the updated holdings of…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4136973:0-atai-merger-agreement-with-eli-lilly-and-company-received-shareholder-approval

ATAI: Merger agreement with Eli Lilly and Company received shareholder approval

4+ day, 11+ hour ago   (58+ words) TradingView ATAI: Merger agreement with Eli Lilly and Company received shareholder approval Shareholders approved the merger agreement with Eli Lilly and Company and Albali Acquisition Corporation. Both proposals on the agenda passed, with final vote results to be published within…...

The Indiana Lawyer
theindianalawyer.com > articles > lilly-fighting-black-market-for-its-next-obesity-drug

Lilly fighting black market for its next obesity drug

4+ day, 11+ hour ago   (1178+ words) Eli Lilly and Co.’s next weight-loss medication is not available. It has not been submitted for regulatory approval. It has not even completed late-stage clinical trials. But if you search “reta” or “retatrutide” on Instagram or TikTok, you will…...

Google News
finance.yahoo.com > healthcare > articles > lilly-builds-neuroscience-long-term-122700438.html

Lilly Builds Neuroscience into a New Long-Term Growth Driver

4+ day, 14+ hour ago   (311+ words) In this article, we will discuss Lilly's position in the neuroscience space and how it is expanding its presence in this area. The relatively small contribution means neuroscience is not yet an important earnings driver for Lilly, but it also…...

Barchart.com
barchart.com > story > news > 4478280 > eli-lilly-vs-novo-nordisk-one-has-39-upside-i-m-picking-the-other

Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other.

5+ day, 4+ hour ago   (922+ words) Obesity is becoming one of healthcare’s biggest long-term challenges, and treating it is creating one of the pharmaceutical industry’s biggest opportunities. For many patients, managing weight goes beyond diet and exercise. Obesity is a chronic disease, and as treatment options…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > eli-lilly-acquisition-spree-much-213500340.html

Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?

5+ day, 5+ hour ago   (280+ words) What's interesting is that Eli Lilly wasn't the first to market with a weight-loss drug in the emerging GLP-1 space. The first company was Novo Nordisk (NYSE: NVO), with Wegovy. But Novo Nordisk struggled to keep up with demand, and…...

TradingView
tradingview.com > news > zacks:ed463f095094b:0-lilly-vs-j-j-betting-on-breakout-growth-or-built-in-stability

Lilly vs. J&J: Betting on Breakout Growth or Built-In Stability?

5+ day, 13+ hour ago   (798+ words) Eli Lilly LLY and Johnson & Johnson JNJ are two leading U.S.-based healthcare companies with strong positions across the pharmaceutical and biotech industries. Both companies continue to deliver strong revenue and earnings growth and have promising long-term prospects. However, which stock…...

Google News
theglobeandmail.com > investing > markets > markets-news > Motley%20Fool > 4466389 > here-s-why-billionaires-stanley-druckenmiller-and-ken-griffin-are-loading-up-on-eli-lilly-stock

Here's Why Billionaires Stanley Druckenmiller and Ken Griffin Are Loading Up on Eli Lilly Stock

6+ day, 17+ hour ago   (416+ words) Griffin's Citadel Advisors and Druckenmiller's Duquesne Family Office bought Lilly stock in Q2. The billionaires likely capitalized on an opportunity with Lilly's shares tumbling early in the quarter. Lilly continues to generate strong revenue and earnings growth. The adage that "birds…...